Physician profile
Britton Blough
NPI 1407111420
$5,439.96
in general payments reported to CMS, 2019-2025
30 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $95.47 · 2021: $341 · 2022: $351 · 2023: $1,248 · 2024: $2,292 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,637 · Travel and Lodging: $1,430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,637.44 |
| Travel and Lodging | $1,429.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,916.34 | 2022-2025 | 2nd Gen Centrimag Primary Console |
| Medtronic, INC. | $1,677.18 | 2024 | Mc3 Nautilus(Tm) Ecmo Oxygenator, Biomedicus |
| La Jolla Pharmaceutical Company | $330.51 | 2021-2024 | Giapreza |
| Merck Sharp & Dohme LLC | $153.93 | 2019-2025 | Zerbaxa |
| Livanova USA, INC. | $147.17 | 2023 | Lifesparc |
| Medtronic Vascular, INC. | $133.04 | 2019 | |
| Csl Behring | $131.58 | 2019-2023 | Kcentra |
| Beyond Air, INC. | $102.36 | 2025 | Lungfit Ph |
| Allergan, INC. | $102.26 | 2019 | |
| Potrero Medical, INC. | $82.94 | 2021 | |
| Pfizer INC. | $67.47 | 2019-2021 | |
| Kci USA, INC. | $62.57 | 2019-2020 | |
| Edwards Lifesciences Corporation | $61.83 | 2024 | |
| Cook Medical LLC | $47.08 | 2019-2021 | |
| Fresenius USA Marketing, INC. | $42.04 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $39.86 | 2019 | |
| Portola Pharmaceuticals, LLC | $38.88 | 2019 | |
| Nestle Healthcare Nutrition INC. | $37.78 | 2021 | |
| Chiesi USA, INC. | $32.37 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $32.07 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $26.60 | 2025 | |
| Shionogi INC | $26.34 | 2023-2024 | Fetroja |
| My01 INC. | $23.13 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Aroa Biosurgery Incorporated | $21.92 | 2023 | |
| Saranas, INC. | $21.76 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $20.80 | 2024 | |
| Melinta Therapeutics, LLC | $17.95 | 2024 | Rezzayo |
| Shire North American Group INC | $15.70 | 2019 | |
| Molnlycke Health Care US, LLC | $15.32 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britton Blough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.